Operating Profit 변화 날짜
AbbVie USD 3.2B 914M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Cara Therapeutics USD -28898000 3.44M 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
J&J USD 4.83B 391M 2023-12
Merck USD -1933000000 7.68B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
P&G USD 4.43B 1.33B 2023-12
Pacira USD 33.17M 15.45M 2023-12
Revance Therapeutics USD -139293000 73.79M 2023-09
Supernus Pharmaceuticals USD -996000 9.13M 2023-12



Revance Therapeutics 영업 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.